Monday, Nov 23, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Health | Scientists Edge Closer To Cutting Hiv Out Of Human Dna

Scientists edge closer to cutting HIV out of human DNA

Scientists are nearing a breakthrough in using CRISPR gene-editing to eliminate HIV from human DNA. Early trials of EBT-101 therapy show it can safely target and cut out viral genes, offering hope for a permanent HIV cure beyond current drug treatments

By M. Sai Gopal
Published Date - 6 October 2025, 12:43 AM
Scientists edge closer to cutting HIV out of human DNA
whatsapp facebook twitter telegram

Hyderabad: The day is not far away when scientists can literally cut the HIV/AIDS virus out of a patient’s cell genome. Geneticists are now very close to developing a CRISPR-based therapy that can be safely delivered throughout the body of a patient to target and edit the latent HIV reservoir, setting the stage to cure HIV.

A few months ago, a US-based company Excision BioTherapeutics presented proof-of-concept data from their CRISPR therapy, EBIT-101, and its promise to target and destroy the HIV reservoir in the human body.


CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), which is a gene-editing tool that acts like molecular scissors, allows scientists to precisely cut and modify DNA.

In this study, phase I and II clinical trials (EBT-101) tested a novel CRISPR-Cas9 gene therapy as a potential functional cure for HIV infection.

At present, there are Antiretroviral Therapies (ART), a combination of proven drugs that keep the HIV virus dormant in the human body.

The primary challenge to curing HIV is the existence of the latent reservoir of infected human cells (T-Cells) where the virus’ genetic material is kept dormant by administering patients with ART therapy. Once the patient stops the ART therapy, the dormant virus reactivates and causes rebound.

The core gene editing technology, which became the basis of the EBT 101 therapy, was developed by two US-based researchers Dr Kamel Khalili (Temple University) and Nobel laureate Dr Jennifer Doudna (UC Berkeley).

The CRISPR-Cas9 system was designed to be directly delivered to the T-Cells and other tissue reservoirs that harbour dormant HIV DNA.

Once inside the infected cell, CRISPR makes multiple cuts across the integrated HIV genome, thus permanently removing large segments of the virus DNA from the body.

The phase I and II trials, which involved a small group of participants, demonstrated that one-time IV infusion of CRISPR therapy was safe and well tolerated, with no serious side effects.

While most participants experienced viral rebound after stopping ART, one participant showed a significantly delayed viral rebound (nearly 16 weeks) and a considerable drop in the size of HIV reservoir compared to other participants in the study.

The breakthrough offered promising signals for future higher-dose applications.

 

 

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • CRISPR HIV cure
  • EBT-101
  • HIV gene editing
  • HIV research

Related News

    Latest News

    • Four centuries highlight HCA C-Division league

      4 minutes ago
    • Agile Valley Warriors clinch Telangana Premier Golf League 2026 title

      7 minutes ago
    • Telugu Black Hawks clinch bronze at CAVA club championship

      13 minutes ago
    • Tilak Varma’s century in vain as India A lose to Pakistan A

      17 minutes ago
    • Liverpool rout Manchester United in Premier League as Pochettino suffers nightmare start

      29 minutes ago
    • Guard of honour for Asaduddin Owaisi in Saharanpur triggers political controversy

      39 minutes ago
    • Editorial: Return of the “human”

      48 minutes ago
    • Sreeleela wishes rumoured beau Kartik Aaryan on birthday, calls him ‘dose of dopamine’

      57 minutes ago

    company

    • Home
    • About Us
    • Contact Us
    • Privacy Policy

    business

    • Subscribe

    telangana today

    • Telangana
    • Hyderabad
    • Latest News
    • Entertainment
    • World
    • Andhra Pradesh
    • Science & Tech
    • Sport

    follow us

    • Telangana Today Telangana Today
    Telangana Today Telangana Today

    © Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

    Telangana Today App